Skip to content

Apotheek Sint-Dimpna

Active
Private limited companyfounded 2024active for 2 yearsRhijn 134, 2440 Geel, BelgiumKBO/BCE: BE 1005.778.152
Summary

Apotheek Sint-Dimpna has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €110,346 and a net result of €91,317. Its solvency ranks better than 31% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€539,460total assets 2025
Staff
1 FTE
Equity
€110,346
Profit
€91,317
Turnover not published (abbreviated format)
Financial health
66 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.2%
Structure
Accounts 3 days early
Why 66raises riskFounded in 2024Sector: Retail trade (NACE 47)Equity €110,346 (20.5% of total assets)lowers riskFigures for financial year 2025 (filed 28-07-2026)Show the evidence

Checked score

Score 2025
66 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 60% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 45+17
equity 20.5% of total assets
Liquidity 21+2
short-term debt 79.5% · cash 11.6%
Profitability 90+78
return on assets 16.9%
Bankruptcy probability, 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 03-2025: 1.8% 04-2025: 1.9%▲ +0.1 percentage points vs 03-2025 05-2025: 1.9%● unchanged vs 04-2025 06-2025: 2.3%▲ +0.4 percentage points vs 05-2025 07-2025: 2.3%● unchanged vs 06-2025 08-2025: 2.6%▲ +0.3 percentage points vs 07-2025highest value 09-2025: 1.4%▼ -1.2 percentage points vs 08-2025 10-2025: 1.5%▲ +0.1 percentage points vs 09-2025 11-2025: 1.5%● unchanged vs 10-2025 12-2025: 1.4%▼ -0.1 percentage points vs 11-2025 01-2026: 1.4%● unchanged vs 12-2025 02-2026: 1.5%▲ +0.1 percentage points vs 01-2026 03-2026: 1.5%● unchanged vs 02-2026 04-2026: 1.6%▲ +0.1 percentage points vs 03-2026 05-2026: 1.5%▼ -0.1 percentage points vs 04-2026 06-2026: 1.7%▲ +0.2 percentage points vs 05-2026 07-2026: 1.8%▲ +0.1 percentage points vs 06-2026 08-2026: 1.4%▼ -0.4 percentage points vs 07-2026 09-2026: 1.4%● unchanged vs 08-2026 10-2026: 1.2%▼ -0.2 percentage points vs 09-2026lowest value
Credit of up to €7,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity insufficient (current ratio 0.76, compared with 0.72 in 2024, below 1; short-term debt: 79.5% and cash: 11.6% of total assets), and 79.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 36% on solvency, 19% on liquidity, 85% on profitability and 98% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Figures for financial year 2025 (filed 28-07-2026)
NBB · annual accounts
raises risk · Equity €110,346 (20.5% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
3 days early
2024
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 11 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Back to profitnet €91,317
  3. Equity above €100,000equity €110,346 ▲480%

Key points

  • Positive: Equity rose in 2025from €19,029 to €110,346 ▲ 480% View
  • Board2 directors in office 2 View
  • Total assets 20252 financial years filed €539,460 View

By topic

Financials

Financial year
2025
Total assets
€539,460
Profit
€91,317
Solvency
20.5%
Total assets▼ 5.3%
Net result
20242025
Go to Financials

Timeline

Events
5
Since
2024
Next accounts
by 31-07-2027
  1. 25-08-2025Annual accounts filed
  2. 12-02-2024Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-02-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Apotheek Sint-Dimpna

What is the company number of Apotheek Sint-Dimpna?
1005.778.152. In Belgium the VAT number is the company number with BE in front: BE 1005.778.152.
Where is Apotheek Sint-Dimpna based?
The registered office is at Rhijn 134, 2440 Geel.Company details
What does Apotheek Sint-Dimpna do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Sint-Dimpna?
Private limited company (BV).
When was Apotheek Sint-Dimpna founded?
On 08-02-2024.
Is Apotheek Sint-Dimpna still active?
Yes, Apotheek Sint-Dimpna is an active enterprise in the KBO register.
How many employees does Apotheek Sint-Dimpna have?
On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Sint-Dimpna?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek Sint-Dimpna profitable?
In financial year 2025, Apotheek Sint-Dimpna made a profit of €91,317.
Where can I find the annual accounts of Apotheek Sint-Dimpna?
Apotheek Sint-Dimpna filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Sint-Dimpna due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Apotheek Sint-Dimpna

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.